Cardiac fibrosis
Open accessThe DOI matches its Crossref record; 612 of the 615 references it cites were found in a registry or an index.
Abstract
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of extracellular matrix proteins, is a common pathophysiologic companion of many different myocardial conditions. Fibrosis may reflect activation of reparative or maladaptive processes. Activated fibroblasts and myofibroblasts are the central cellular effectors in cardiac fibrosis, serving as the main source of matrix proteins. Immune cells, vascular cells and cardiomyocytes may also acquire a fibrogenic phenotype under conditions of stress, activating fibroblast populations. Fibrogenic growth factors (such as transforming growth factor-β and platelet-derived growth factors), cytokines [including tumour necrosis factor-α, interleukin (IL)-1, IL-6, IL-10, and IL-4], and neurohumoral pathways trigger fibrogenic signalling cascades through binding to surface receptors, and activation of downstream signalling cascades. In addition, matricellular macromolecules are deposited in the remodelling myocardium and regulate matrix assembly, while modulating signal transduction cascades and protease or growth factor activity. Cardiac fibroblasts can also sense mechanical stress through mechanosensitive receptors, ion channels and integrins, activating intracellular fibrogenic cascades that contribute to fibrosis in response to pressure overload. Although subpopulations of fibroblast-like cells may exert important protective actions in both reparative and interstitial/perivascular fibrosis, ultimately fibrotic changes perturb systolic and diastolic function, and may play an important role in the pathogenesis of arrhythmias. This review article discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with reduced or preserved ejection fraction, genetic cardiomyopathies, and diabetic heart disease. Development of fibrosis-targeting therapies for patients with myocardial diseases will require not only understanding of the functional pluralism of cardiac fibroblasts and dissection of the molecular basis for fibrotic remodelling, but also appreciation of the pathophysiologic heterogeneity of fibrosis-associated myocardial disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction1,2.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [2]
In the citing paper
“Among stromal cell types, fibroblasts are of particular interest given their role in tissue fibrosis, arrhythmias, and heart failure 16,29,30 .”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [30]
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495 · cited 1×
“Fibrosis is an important cause of organ dysfunction in many different diseases, including interstitial lung diseases, liver cirrhosis, progressive systemic sclerosis, and diabetic nephropathy.(1)”
BackgroundMyofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222 · cited 2×
“The antifibrotic effects were attributed to blockade of TGF-b signalling and were associated with attenuated endothelial to mesenchymal transition.(22,247) Moreover, gain-of-function studies have”
BackgroundHinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Cited by
Items 901–1,000 of 1,000
Xia, Y., Yuan, Q., Liu, X., Wang, G., & Bian, Y. (2025) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2025.100024 · Cited by 2
Exercise Empowerment: A Multifaceted Anatomy in Managing Diabetic Myocardial Disorder
Chen, C., Xu, L., Wang, K., & Wang, T. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10630-1 · Cited by 1
“It also promotes fibrosis either through direct action on cardiac fibroblasts or through action on other types of cardio-myocytes[215].”
Plasmapheresis as a Potential Generalizable Therapy for Myocardial Infarction
Cruz, J. M. C., Lozano-Gerona, J., Manua, A. J., Agsaoay, M. L. J. S., Pedro, J. V. S., Conboy, I. M., Mazahery, A. R., & Nevado, J. B. (2025) · Rejuvenation Research · doi:10.1089/rej.2025.0015 · Cited by 1
Okenov, A., Nezlobinsky, T. V., Glashan, C. A., Zeppenfeld, K., Vandersickel, N., & Panfilov, A. V. (2025) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ade6bb · Cited by 1
Bian, W., & Guo, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1590711 · Cited by 1
Mechanism validation of the saponins from American ginseng in antagonizing chronic heart failure
Tian, J., Tang, M., Geng, Y., Zhang, B., Cai, G., Li, J., Tao, Y., Gong, J., & Yang, Z. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107170 · Cited by 1
He, S., Jiang, J., Zhang, Y., Liu, T., Deng, W., Xie, Y., Li, W., Tan, Y., Fang, L., Zhang, J., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1603082 · Cited by 1
Molecular Mechanisms of Cardiac Adaptation After Device Deployment
Romano, L. R., Plutino, P., Lopes, G., Quarta, R., Calvelli, P., Indolfi, C., Polimeni, A., & Curcio, A. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12080291 · Cited by 1
“Given its pervasive impact on myocardial function, targeting fibrotic remodeling is essential for supporting decision-making or improving the long-term efficacy of implantable cardiac devices and advancing HF management [84] (Box 1).”
Que, X., He, F., He, Q., Lim, J., Li, X., Meng, X., & Yang, Z. (2025) · Cardiology Research and Practice · doi:10.1155/crp/7765150 · Cited by 1
“While renin-angiotensin-aldosterone system (RAAS) agents and calcium channel blockers inhibit MF, their long-term use poses risks [1].”
Alkhatib, B., Purswani, D., Dantam, A., Razan, M. R., Jabari, M., Padmanabhan, V., & Vyas, A. K. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00433.2025 · Cited by 1
Safety and Prognostic Value of Left Ventricular Endomyocardial Biopsy in Dilated Cardiomyopathy
Kayvanpour, E., Sedaghat‐Hamedani, F., Li, D. T., Amr, E., Amr, A., Lahrmann, B., Lai, A., Reich, C., Wang, C., Herpel, E., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70019 · Cited by 1
“…matrix such as elastic fibers, glycoproteins, proteoglycans, growth factors, cytokines, and proteases and can be estimated by CVF. 4 1 ,42 Thus, increased CVF through increased production or decreased degradation of collagen is, regardless of the aetiology, associated with increased…”
Garcia, J. L., D’Amato, A., Siqueira, J. S., Francisqueti‐Ferron, F. V., Gregolin, C. S., Bazan, S. G. Z., Ferron, A. J. T., Sormani, L. E., Vieira, T. A., Lopes, B. P., et al. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70239 · Cited by 1
Lysyl oxidase in the pathology of the heart
Дремина, Н. Н., Сергеевна, Т. И., Александровна, Ш. И., & Шурыгин, М. Г. (2025) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2025-10.4.4 · Cited by 2
Lü, Y., Li, Y., Can, Z., Guo, M., Liu, X., & Chen, X. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100798 · Cited by 1
“Importantly, MyoFbs not only contribute to excessive ECM deposition at sites of injury but also induce reactive fibrosis in remote myocardial areas through paracrine mechanisms, establishing a “fibrosis diffusion” effect [6].”
Bovine milk exosomes influence transcriptome profiles and reduce cardiac fibrosis in a rat model
Hu, J., Lu, X., Yan, J., Wang, J., Zhang, J., Zhu, H., Wang, E., & Zhang, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-19160-x · Cited by 1
Xiong, Q., Yang, L., Peng, C., Ma, S., Yan, P., Duan, Y., Chen, D., Tong, W., Yang, R., Huo, Z., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00924.2024 · Cited by 1
Chu, Y., Zhu, J., Chen, S., Lin, X., Zhou, Z., Shen, R., Wang, H.-S., Chen, L., Lin, J., Zhang, H., et al. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.10.006 · Cited by 1
Zhao, W., Tang, R., Zhang, Y., Huo, Y., & Lian, Q. (2025) · Medicine · doi:10.1097/md.0000000000045121 · Cited by 1
“[1] Hypertension represents a significant global public health challenge and is a leading contributor to elevated morbidity and mortality from cardiovascular diseases.”
Wang, D., Zhou, S., Tang, Y., Liang, Z., Yu, X., Huang, G., Huang, C., Wang, S., & Liu, H. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103887 · Cited by 1
“Besides, immune cells, vascular cells and cardiomyocytes may also acquire a fibrogenic phenotype under conditions of stress, activating fibroblast populations [38].”
An, Y., Sun, G., Dong, Z., Liu, Y., Huang, Y., Cheng, X., Zheng, W., Du, J., Li, N., Zhang, Y., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.170400 · Cited by 1
Warren, C. M., Ryba, D. M., Geist, G. E., Coronado, A. C., Wolska, B. M., Goldspink, P. H., & Solaro, R. J. (2025) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2025.100495 · Cited by 1
Cardiac Digital Twins—Computational Approaches for Personalized Arrhythmia Care
Rajawat, K. (2025) · IITK directions · doi:10.1007/978-981-96-8606-3_9 · Cited by 3
Role of SOX9 in cardiovascular diseases: Evidence today
Chadha, A. N., Cheng, H., & Yang, J. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i11.110339 · Cited by 1
Ciortan, L., Gan, A., Cecoltan, S., Serbanescu, M. A., Mihaila, A. C., Macarie, R. D., Tucureanu, M. M., Naie, M. L., Preda, M. B., Cosman, B.-P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13112829 · Cited by 1
Peng, J., Hu, L., Xiao, P., Xiang, T., Huang, M., Li, R., Lei, J., Yang, Z., & Dai, X. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05270-x · Cited by 1
“However, several evidences have shown that the expression levels of a variety of inflammatory factors (TNF-α, IL-1β, IL-6) in myocardial fibrosis are significantly increased, and are closely related to the severity of myocardial fibrosis [32].”
Single cell transcriptomic landscape of adult and pediatric non-ischemic cardiomyopathy
Tadros, H. J. J., Turaga, D., Hope, K. D., Spinner, J. A., Adachi, I., Li, X., & Martin, J. F. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.12.002 · Cited by 1
Mechanotransduction as an emerging pathophysiological determinant of cardiovascular diseases
Capoulade, R., & Smart, N. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf275 · Cited by 1
Research advances in self-assembled peptide delivery systems for fibrosis treatment
Zhang, Y., Su, D., & Wang, Y. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100043 · Cited by 2
Cortes, D. R. E., Becker-Szurszewski, T., Hartwick, S., Amjad, M. W., Mohammed, S. A., Chen, X., Pacella, J. J., Christodoulou, A., & Wu, Y. L. (2025) · Biomolecules · doi:10.3390/biom15121732 · Cited by 1
Molecular insights in HIV-associated cardiac dysfunction
Valero‐Muñoz, M., Saw, E. L., Pimentel, D. R., Gower, A. C., Srinivasa, S., Zanni, M. V., Toribio, M. P., Grinspoon, S. K., & Sam, F. (2025) · Communications Medicine · doi:10.1038/s43856-025-01349-w · Cited by 1
Wang, S., Wu, T., Dai, J., Liu, X., He, L., Dong, Y., Zhao, L., & Li, N. (2025) · Toxics · doi:10.3390/toxics14010052 · Cited by 1
Zhang, Y., Li, N., Chu, S., Fu, H., Yang, X., Xia, H., Xiao, Y., Xiao, Z., Liu, J., Dong, Y., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1723889 · Cited by 1
“The main cause of cardiac fi brosis is ECM remodelling, which is based on a phenotypic shift in cardiac fi broblasts from myo fi broblasts to fi broblasts under pressure overload or other pathological conditions (Frangogiannis, 2021).”
Yalçın, F., Küçukler, N., Çağatay, B., Abraham, M. R., Abraham, T. P., & Garcia, M. J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020623 · Cited by 1
“This metabolic deterioration activates profibrotic signaling, leading to increasing interstitial fibrosis, loss of regional compliance, and progressive impairment of contractile reserve [66,67].”
Jin, W., & Qiao, X. (2026) · Molecular & Cellular Toxicology · doi:10.1007/s13273-026-00603-z · Cited by 1
“…rise in the synthesis and release of matrix components that are excessively deposited in the interstitium of cardiomyocytes or in the perivascular area, which in turn interferes with electrophysiological activity and contractile function of cardiomyocytes (Frangogiannis 2021; Umbarkar et al. 2021).”
Hassan, F. E., Hassanien, M. M., Selmy, A., Mahmoud, L. M., Darwish, A., & Aldreny, B. A. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1752370 · Cited by 1
“Afterwards, myocardial cells trigger an inflammatory reaction, leading to myocardial fibrosis and ultimately heart failure (Frangogiannis, 2021).”
The Hippo pathway in cardiac fibrosis: mechanisms and therapeutic prospects
Qiu, Y., Hu, S., Li, H., Ren, J., Liao, M., Huo, J., Luo, Z., & Lu, L. (2026) · Human Cell · doi:10.1007/s13577-026-01352-w · Cited by 1
“Cardiac fibroblasts (CFs) are the primary cell type responsible for promoting tissue repair and generating the ECM, playing a crucial role in the development of cardiac fibrosis [21].”
Mansouri, Z., Dianat, M., Badavi, M., Asadirad, A., Akiash, N., & Mard, S. A. (2026) · The FASEB Journal · doi:10.1096/fj.202501842rr · Cited by 1
Black, N., Lewis, G. A., Soltani, F., Dodd, S. R., Schelbert, E. B., Ravassa, S., López, B., González, A., Cleland, J. G. F., & Miller, C. (2026) · Open Heart · doi:10.1136/openhrt-2025-003596 · Cited by 1
Morales-Vazquez, H. N., Cardona‐Müller, D., Grover‐Páez, F., Ramos-Becerra, C. G., Cardona-Muñóz, E. G., Ramos-Zavala, M. G., Carmona-Huerta, J., Río, J. E. H.-D., Miranda-Aquino, T., González-Padilla, C., et al. (2026) · Life · doi:10.3390/life16020319 · Cited by 1
“Growth factors such as TGF-β and PDGF, along with persistent inflammatory cytokine exposure (TNF-α , IL-1, IL-6, IL-10, and IL-4) may promote myocardial fibrosis and remodeling, creating an arrhythmogenic substrate [12,13].”
Liu, X., Zhang, C., Jiang, W., Wu, J., Li, G., Zhao, J., Sun, X., Huang, J., & Zhao, L. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05165-4 · Cited by 1
“…feature in various heart diseases, is characterized by the excessive accumulation of extracellular matrix (ECM) proteins in the Xiang Liu and Chunyu Zhang contributed equally to this work. myocardium, leading to increased stiffness and reduced myocardial elasticity (Frangogiannis 2020).”
MsrB2 deficiency amplifies ECM-driven cardiac fibrosis under hypertensive stress
Yun, J. H., Cho, S., Lee, J. Y., Kim, S., & Lee, S. H. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1772933 · Cited by 1
“Cardiac fibrosis, a hallmark of adverse cardiac remodeling, is characterized by excessive accumulation and cross-linking of extracellular matrix (ECM) proteins, leading to myocardial stiffening and dysfunction (Frangogiannis, 2021).”
Sandstedt, M., Johansson, M., Jonsson, M., Vukušić, K., Ulfenborg, B., Sandstedt, M., Hultén, L. M., Sopasakis, V. R., Dellgren, G., Jeppsson, A., et al. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00921.2025 · Cited by 1
Decoding Fibroblast Diversity Associated with the Postnatal Loss of Cardiac Regenerative Capacity
Aghagolzadeh, P., Rapp, V., Nemir, M., Mahfoud, F., Brink, M., & Pedrazzini, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062709 · Cited by 1
Zhu, C., Xue, Y., Hong, W., Zhu, Y., Miao, X., Guo, Y., Xu, Y., Fang, M., & Kong, M. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag066 · Cited by 1
Zhao, J., Yan, Z., Guan, C., Li, D., Yan, X., Xiao, L., Li, Y., Liu, X., & Tang, S. (2026) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.106697 · Cited by 1
Chen, P., Lee, T., Liu, S.-H., Cheng, T.-Y., Kao, Y., & Chen, Y. (2026) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.25.1392 · Cited by 1
Cheng, T., Gan, L., & Yao, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073186 · Cited by 1
Zou, L., Zhang, H., Fan, J., Chen, W. W., Ling, Z., & Yin, Y. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70814 · Cited by 1
Liu, R., Feng, X., Ji, H., Shan, Y., Cao, R., & Xu, L. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119349 · Cited by 1
Bagchi, S., Cai, A., Bilal, A. S., Gamez-Luque, J., Rosa‐Garrido, M., Patton, B. K., Kala, M., Glembotski, C. C., & Blackwood, E. A. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100846 · Cited by 1
“While CFB promote wound-healing in adaptive contexts, they can also promote pathological fibrotic remodeling when their activity is unconstrained or dysregulated [28,29].”
Reversible Fibroblast Trajectories Regulated by MR Underlie Diastolic Dysfunction
Meral, D., Mamazhakypov, A., Koca, D., Mukherjee, D., Kamaras, C., Emig, R., Peyronnet, R., Preißl, S., & Lother, A. (2026) · Circulation Research · doi:10.1161/circresaha.125.327301 · Cited by 2
Leptin Receptor Fibroblasts Are Preferential Contributors to Cardiac Fibrosis
Larcher, V., Fischer, A., Zhang, L., Almolla, O., Chiesa, M., Andriani, F., Wernet, C., Serio, S., Tombor, L., Peruzzo, S., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327701 · Cited by 2
“2,3 Several studies have shown that most activated CFs arise from preexisting quiescent CFs 4–7 ; however, it remains unclear whether all preexisting CFs contribute equally to fibrotic processes.”
VAP1 promotes cardiac fibrosis by enabling PDGFR signaling in myofibroblasts
Huang, S., Zhao, Q., Shao, T., Zhu, C., Xue, Y., Chen, N., Zhang, Y., Xu, H., Kong, M., & Wang, R. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01690-7 · Cited by 1
Lim, Y., Jeong, A., Kwon, D., Lee, Y.-G., Lee, Y.-U., Cho, H. J., Kee, H. J., Yoon, S., Yoon, H., Kim, Y., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01698-z · Cited by 1
Targeting YAP: mechanistic breakthroughs and therapeutic prospects in reversing organ fibrosis
Fu, K., Cao, M., Wang, Y., Luo, J., & Yuan, W. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05540-y · Cited by 1
“Hence, strategies that specifically block fibro - blast-to-myofibroblast differentiation are being pursued as potential treatments for cardiac fibrosis [121 – 123].”
Endothelial MerTK impairment promotes cardiac dysfunction in the condition of high fat diet
Huang, H., Liu, S., Yao, J., Bai, X., Jin, Z., Xue, B., Shi, H., & Ding, Z. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104184 · Cited by 1
Cao, X.-Y., Tu, B., Cao, Z.-R., Liu, F., Yan, G., Dong, J. X., Huang, Q.-W., Li, Z.-J., Liu, Q., Leng, J.-J., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08163-5 · Cited by 1
Boottanun, P., Nagai‐Okatani, C., Kawanishi, K., Baba, M., Nakatsukasa, T., Ishizu, T., Angata, K., & Kuno, A. (2026) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-026-06501-6 · Cited by 1
“Fibrotic tissues are dominated by dense ECM structures in which parenchymal cells are partially or completely replaced [2].”
Cruz, J. M. D., Alzalzalee, R., Yeung, H., Mahmood, Z., Yang, Q., Morshedian, N., Robinson, Z. R., Malhotra, K. R., Conboy, M. J., Mazahery, A. R., et al. (2026) · Aging Cell · doi:10.1111/acel.70525 · Cited by 1
CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction
马灿杰, Jia, J., Lan, J., Wang, J., Rao, D., Rao, L., Zhang, W., Wu, D., Zhang, J., Wang, G., et al. (2026) · Advanced Science · doi:10.1002/advs.75560 · Cited by 1
“This structural remodeling leads to ventricular stiffening and electromechanical dysfunction, ultimately contributing to the progression toward overt heart failure [ 5 ].”
Therapeutic strategies for ischemic heart disease with natural product-based nanomedicines
Qu, P., Jia, F., Liu, X., Wang, Y., Li, C., Lu, J., Guo, H., Qian, L., Guan, H.-W., Qu, H., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04481-4 · Cited by 1
Conserved Transcriptional Circuits Regulate Cardiac Fibroblast-Mediated Fibrosis
Krstevski, C., Farrugia, G. E., Hsu, I., Dona, M. S. I., Gaynor, T. L., Cohen, C. D., Harper, R. L., Harrison, T. I., Raffaut, S. R., Claridge, B., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327294 · Cited by 1
“42 Critical for identifying the core TFs regulating fibrosis and the Fibro-CT phenotype we have identified was the comparison of human and mouse Fibro-CT cells.”
Adverse cardiac effects of ultrasonic vaping devices despite lack of heating coil
Goyal, N., Kavuri, M., Wang, P., Wang, Z.-M., Derakhshandeh, R., Qiu, H., Wang, X., Cheng, J., Kumagai, K., & Springer, M. L. (2026) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntag102 · Cited by 1
Tan, D., Lye, Y. E., Patel, P., Minn, N. A., Le, A. C., Bobik, A., & Kyaw, T. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104409 · Cited by 1
“Ang II subsequently engages the angiotensin II type-1 receptor (AT1R) on cardiac fibroblasts, triggering downstream activation of extracellular signal-regulated kinase 1/2 (ERK1/2), p38 mitogen-activated protein kinase (p38 MAPK), and PKC pathways [66].”
Bi, S., Wang, J., Shi, X., Wen, H., Zhao, W., Liu, S., Wang, Z., & Yao, Z. (2026) · Small · doi:10.1002/smll.202513213 · Cited by 1
Dou, X., Wan, H., Chen, T., Zhou, H., Li, Y. X., & Wan, H. (2026) · Pharmaceuticals · doi:10.3390/ph19050755 · Cited by 1
“…or inflammation in the heart leads to enhanced oxidative stress and imbalance of the synthesis and degradation of extracellular matrix (ECM) [3], and causes excessive deposition of collagen fibers and spatial structure remodeling, eventually leading to increased myocardial stiffness,…”
Suastika, L. O. S., Bando, Y., Hoshino, K., Koitabashi, N., Saito, Y., Yuasa, S., & Nakamura, K. (2026) · Nutrients · doi:10.3390/nu18111688 · Cited by 1
Nisar, A., Khan, S., Li, W., (56049), X. Z., & He, Y. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109055 · Cited by 1
Ashour, L., Obar, M., Yaser, A., Fraihat, Q. A., Abuqudaira, B., Ebeidat, N., Al-Ghwiery, L., Zaita, M., Subbah, E., Kaoukji, A., et al. (2026) · PubMed Central · doi:10.19102/icrm.2026.17056 · Cited by 1
Reductive stress in myocardial Ischemia: Mechanisms, pathophysiology, and therapeutic perspectives
Kurian, G. A. (2026) · Biochimie · doi:10.1016/j.biochi.2026.06.003 · Cited by 1
Yang, Q., Zhang, S., Dang, M., Taub, C. C., Lee, C., Chen, F., Teng, Z., & Yao, J. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.102974 · Cited by 1
Huang, Y., Luo, L., Ma, X., Huang, Y., Zhang, C., Hao, X., Zhang, L., Zhu, H., Dai, L., & Liu, M. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047429 · Cited by 1
“57 In multihit models that combine hypertensive stimuli with other metabolic or stress factors, distinct macrophage alterations are observed.”
Xing, Y. (2026) · BIO Web of Conferences · doi:10.1051/bioconf/202624001022 · Cited by 1
Gonçalves, L. L., Vieira-Alves, I., NICOLI, E. F., Lima, D. S. S., Lemos, V. S., Peluso, A. A., Endlich, P. W., de Almeida, S. A., & Abreu, G. R. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71262 · Cited by 1
Zhao, X., Hua, L., Xiong, Y., Shi, F., Zhong, Y., Zhang, S., & Tian, C. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1858990 · Cited by 3
Zeman, M., Matiko, Z., Moravčík, R., Horvath, C. G., Sýkora, M., Marciníková, A., Šutovská, H. M., Benedikova, B., Andelová, K. O., Molčan, Ľ., et al. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110463 · Cited by 1
Stefani, S., da Silva, G. J. J., Cardinali, M. A., Parvan, R., Cevoli, G., Sassi, P., & Cataliotti, A. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2026.128435 · Cited by 1
Ciaccio, E. J., Hsia, H. H., Talke, M., Schwartz, S. M., Garan, H., Yarmohammadi, H., Peters, N. S., Coromilas, J., & BIVIANO, A. B. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.07.017 · Cited by 2
Ding, Y., Xue, B., Guan, S., Gao, M., Sun, X., Li, Q., & Liu, J. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127197 · Cited by 1
Cardiac fibroblasts in extracellular matrix homeostasis and remodeling
Ibrahim, S., Sadaka, K., Shepard, M. E., Bagchi, A. K., & Bagchi, R. A. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00862.2025 · Cited by 1
Ankyrin Repeat Domain 1: A Key Regulatory Factor and Emerging Therapeutic Target in Heart Disease
Wang, Z., Du, Q., & Zhang, S. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm48749 · Cited by 1
“The triggers for myocardial remodeling signals are diverse, including myocardial infarction, ischemic/reperfusion injury following coronary artery revascularization and cardiopulmonary bypass surgery, pressure and volume overload, as well as neuroendocrine activation [31].”
Arenas, G. A., Herrera, E. A., Krause, B. J., Giussani, D. A., Julian, C. G., MOORE, L. G., & Lorca, R. A. (2026) · Physiological Reviews · doi:10.1152/physrev.00003.2026 · Cited by 1
Mechanics of compression-driven morphogenesis
Tan, J. Y. K., & Chan, C. J. (2026) · Development · doi:10.1242/dev.205781 · Cited by 2
“Fibrosis is largely driven by the activation of fibroblasts into contractile myofibroblasts, which tend to secrete abundant ECM components (Frangogiannis, 2021).”
Ahad, A., Hullon, D., Akhavan, M., & Oskouyan, Z. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10839-8 · Cited by 1
“First, the TGF-beta/SMAD axis, of which myostatin is the principal muscle-specific effector, governs not only muscle catabo - lism but also cardiac fibrosis, adipogenic differentiation, and inflammatory gene expression through SMAD2/3-dependent transcription [13, 15].”
InfluentialCardiac fibrosis: mechanistic insights and translational advances
Xie, H.-Y., Zheng, X.-T., Wang, X.-H., Yang, J.-Y., Liu, Y.-X., Zhao, Y., Tang, H., & Hu, H.-J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00587-1 · Cited by 1
Bayer, A. L., Emig, R., Kley, C., Zambrano, M. A., Robbe, Z. L., Narvaez-Paliza, J. M., Alilou, S., Powers, S., Upshaw, J. N., Asnani, A. H., et al. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2026.09.001 · Cited by 1
The era of in vivo T cell engineering
Ramos, G. C., & Hudecek, M. (2022) · Med · doi:10.1016/j.medj.2022.01.012 · Cited by 1
Digitalis purpurea Improve Obesity Inducing Alternation of Cardiac Infarction: A Meta Analysis
Keshamma, E., Sohi, S., Harshita, Kumar, V., Shanko, A., Pasupulla, A. P., & Kumar, A. (2022) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2022/v34i234843 · Cited by 1
At the forefront of basic and translational Cardiovascular Research for 55 years and counting
Guzik, T. J., Sipido, K. R., Brown, S. K., & Casadei, B. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac169 · Cited by 1
Шарапченко, С. О., Mamedova, A. A., & Shevchenko, O. P. (2023) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2023-2-148-157 · Cited by 1
Xiang, W., Zhou, N., Li, L., Chen, F., Li, L., & Wang, Y. (2023) · Cells · doi:10.3390/cells12172186 · Cited by 1
“However, recent advances have shed light on their essential role in sensing environmental stress stimuli and communicating with various cell types [1].”
BackgroundWilk, B., Smailovic, H., Sullivan, R., Sistermans, E. R., Butler, J., Jago, H., Kovacs, M. S., Wisenberg, G., Thiessen, J. D., & Prato, F. S. (2023) · EJNMMI Research · doi:10.1186/s13550-023-01040-y · Cited by 1
“Representative histological images of each are shown on the left the volume [23], while the extracellular volume (ECV) occupies approximately 0.2 mL/mL (Fig.”
BackgroundInfluentialJacobs, E. R., Ross, G. R., Padilla, N., Pan, A., Liegl, M., Puzyrenko, A., Lai, S., Dai, Q., Uche, N., Rubenstein, J., et al. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.10.006 · Cited by 1
Signaling pathways in cardiac fibrosis; A review and future therapeutic options
Elsayed, M. O. K., Moustafa, Y. M., Mehanna, E. T., El-Sayed, N. M., & Hazem, R. M. (2023) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2023.238923.1244 · Cited by 1
Фиброз миокарда – защитный механизм или основная причина неблагоприятных исходов?
Трошин, Д. С., Аверина, И. И., Александрова, С. А., Марченко, Д. С., & Донаканян, С. А. (2023) · Kreativnaya kardiologiya · doi:10.24022/1997-3187-2023-17-4-464-473 · Cited by 1
Lysine demethylase 5B transcriptionally regulates TREM1 in human cardiac fibroblasts
LIANG, C., Chen, J., CHEN, X., Yan, W., & Yu, J. (2024) · Biocell · doi:10.32604/biocell.2024.050509 · Cited by 1
Lu, S., Noble, T., Elkins, J., Jolly, A., Dubner, A., Jacot, J. G., Peña, B., Hardy, E. J., Nemenoff, R. A., Moulton, K. S., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324849 · Cited by 1
Goetz, W. A., Brener, M. I., Puri, R., Swaans, M., Schopka, S., Wiesner, S., Creuztenberg, M., Sievert, H., Kassab, G. S., & Yao, J. (2024) · Bioengineering · doi:10.3390/bioengineering11060603 · Cited by 1
Radiology of fibrosis. Part I: Thoracic organs
Tarchi, S. M., Salvatore, M. M., Lichtenstein, P., Sekar, T., Capaccione, K. M., Luk, L., Shaish, H. A., Makkar, J. S., Desperito, E., Leb, J. S., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05244-1 · Cited by 1
“Myocardial fibrosis consists of excessive expansion of the cardiac interstitium through deposition of ECM proteins, often leading to impaired electric conductance and reduced systolic and diastolic function [101–103].”
BackgroundMariano, L., Mariano, T. B., Floriano, R. S., Gomes, M. J., Engel, L. E., Nai, G. A., & Pacagnelli, F. L. (2024) · Toxicology Research · doi:10.1093/toxres/tfae184 · Cited by 1
Metadata
- Authors
- Frangogiannis, N. G.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Frangogiannis, Nikolaos G
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-02
- Volume
- 117
- Issue
- 6
- Pages
- 1450-1488
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC8152700
- OpenAlex
- W4210607007
- Cited by
- 1,229
- References
- 615
- Citations by year
- 2026: 265 · 2025: 319 · 2024: 273 · 2023: 210 · 2022: 130 · 2021: 32
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Cardiovascular Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R01 HL76246, R01 HL85440, R01 HL149407)
- U.S. Department of Defense (PR151134, PR151029, PR181464)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- myocardial fibrosis, myocardial fibroblasts, myofibroblasts, extracellular matrix deposition, TGF-beta, platelet-derived growth factor, cytokines, mechanoreceptors, integrins, pressure overload, myocardial infarction, heart failure, familial cardiomyopathy, diabetic cardiomyopathy, cardiac arrhythmias
- MeSH terms
- Antifibrotic Agents, Animals, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Cardiomyopathies, Myocytes, Cardiac, Mechanotransduction, Cellular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.